FBIO - Fortress Biotech Inc
1.72
-0.020 -1.163%
Share volume: 120,569
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.74
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-14-2024 | |
| Total revenue | 13.030 M | 14.896 M | 14.629 M | |
| Cost of revenue | 6.816 M | 6.541 M | 5.285 M | |
| Gross profit | 6.214 M | 8.355 M | 9.344 M | |
| 34.45% | 11.84% | |||
| Operating expenses | 42.780 M | 33.494 M | 31.439 M | |
| Selling general and admin | 17.941 M | 20.823 M | 21.993 M | |
| Research and development | 24.839 M | 12.671 M | 9.446 M | |
| Total expenses | 42.780 M | 36.143 M | 31.439 M | |
| -15.51% | -13.01% | |||
| Operating income | -36.566 M | -27.788 M | -22.095 M | |
| Ebit | -37.254 M | -27.436 M | -21.005 M | |
| Pretax income | -39.023 M | -28.824 M | -26.625 M | |
| -26.14% | -7.63% | |||
| Income tax | 0.000 | 0.000 | 69.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -39.023 M | -28.824 M | -26.694 M | |
| 26.14% | 7.39% |
